MiR-221/SIRT1/Nrf2 signal axis regulates high glucose induced apoptosis in human retinal microvascular endothelial

Bin Chen1, Li Wu1, Ting Cao1

  • 1Department of Ophthalmology, Renmin Hospital of Wuhan University, No. 238, Jiefang Road, Wuhan, 430060, Hubei Province, P. R. China.

BMC Ophthalmology
|July 24, 2020
PubMed
Abstract

Insights

MicroRNA-221 promotes diabetic retinopathy (DR) by increasing apoptosis in retinal cells. It targets SIRT1, inhibiting the Nrf2 pathway, offering potential therapeutic targets for DR.

Area of Science:

  • Ophthalmology
  • Molecular Biology
  • Cell Biology

Background:

  • Diabetic retinopathy (DR) is a diabetes complication impacting vision.
  • MiR-221, SIRT1, and Nrf2 are implicated in cell apoptosis and proliferation, with altered expression in DR.
  • The precise roles of these molecules in human retinal microvascular endothelial cells (hRMEC) were unclear.

Purpose of the Study:

  • To investigate the roles and regulatory mechanisms of miR-221, SIRT1, and Nrf2 in hRMEC under high glucose conditions.
  • To elucidate the signaling pathway involving miR-221, SIRT1, and Nrf2 in DR pathogenesis.

Main Methods:

  • Gene expression analyzed via qRT-PCR and Western blot.
  • MiR-221 and SIRT1 interaction validated using bioinformatics and dual-luciferase reporter assays.
  • Cell viability and apoptosis assessed using MTT and FACS assays.

Main Results:

  • High glucose increased miR-221 expression while decreasing SIRT1 and Nrf2.
  • Overexpression of miR-221 enhanced apoptosis in hRMEC under high glucose.
  • MiR-221 directly targets SIRT1 mRNA, inhibiting SIRT1 expression and consequently suppressing the Nrf2 pathway, leading to hRMEC apoptosis.

Conclusions:

  • The miR-221/SIRT1/Nrf2 axis promotes apoptosis in hRMEC under high glucose.
  • This pathway provides a potential therapeutic target for mitigating diabetic retinopathy progression.